Get started Log in

FUSN — Fusion Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Market Cap
$1.83bn
Enterprise Value
$1.67bn
Revenue
$2.07m

Fusion Pharmaceuticals Inc expected to post a loss of 40 cents a share - Earnings Preview
03/11/2023 16:50
Brief: Avidity Partners Management Reports 9.7% Passive Stake In Fusion Pharmaceuticals As Of Oct 18- SEC Filing
23/10/2023 22:56
Brief: Fusion Pharmaceuticals Appoints Jeremy Bender, Teresa Bitetti And David Meek To Board
16/10/2023 12:59
Fusion Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
08/08/2023 13:30
Fusion Pharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
04/08/2023 19:38
Brief: Fusion Pharmaceuticals Files For Shelf Of Up To 4.8 Mln Shares By Selling Stockholders
16/06/2023 21:05
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
11/05/2023 14:27
Brief: Fusion Pharmaceuticals Announces Q1 2023 Financial Results, Clinical Program Updates
11/05/2023 13:00
Brief: Fusion Pharmaceuticals Announces Q1 2023 Financial Results And Clinical Program Updates
11/05/2023 12:56
Fusion Pharmaceuticals Inc expected to post a loss of 32 cents a share - Earnings Preview
05/05/2023 19:34
Brief: Fusion Pharmaceuticals Announces Opening Of Radiopharmaceutical Manufacturing Facility
02/05/2023 22:16
Brief: Fusion Pharmaceuticals Announces IND Clearance For FPI-2068, A Jointly Developed Novel Targeted Alpha Therapy
12/04/2023 21:25
Brief: Fusion Pharmaceuticals Announces First Patient Dosed In Phase 1 Study Of Fpi-2059, A Targeted Alpha Therapy (Tat) For The Treatment Of Solid Tumors Expressing Ntsr1
20/03/2023 20:11
Brief: Fusion Pharmaceuticals Announces First Patient Dosed In Phase 1 Study Of FPI-2059, A Targeted Alpha Therapy (Tat) For The Treatment Of Solid Tumors Expressing Ntsr1
20/03/2023 20:08
Brief: Fusion Pharmaceuticals Files For Resale Of Up To 17.65 Mln Common Shares By Selling Shareholders
16/03/2023 22:40
Fusion Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
16/03/2023 12:35
Brief: Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results
16/03/2023 11:46
Fusion Pharmaceuticals Inc expected to post a loss of 56 cents a share - Earnings Preview
13/03/2023 14:40
Brief: Fusion Pharmaceuticals Inc Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank
10/03/2023 23:32
U.S. STOCKS ON THE MOVE-Packaged food makers, energy firms, Thomson Reuters
14/02/2023 19:02